5. Conclusions
The studies summarized in this chapter demonstrate that the failure to maintain DNA methylation patterns in mature CD4+ T cells causes aberrant expression of several methylation-sensitive genes, including LFA-1, perforin, CD70, and likely others, and that their overexpression alters T cell function, promoting autoreactivity, monocyte/macrophage killing, and B cell overstimulation. Furthermore, T cells experimentally demethylated with DNA methyltransferase or ERK signaling pathway inhibitors cause a lupus-like disease in murine models. Procainamide and hydralazine are DNA methylation inhibitors and cause a lupus-like disease in genetically susceptible individuals. Patients with idiopathic lupus have hypomethylated DNA, overexpress the same genes due to the same changes in DNA methylation patterns as in the methylation inhibition model, and demonstrate identical changes in CD4+ T cell function including autoreactive, perforin-mediated monocyte killing and B cell overstimulation. Thus, similar changes in DNA methylation and chromatin structure likely contribute to the pathogenesis of autoimmunity in the DNA hypomethylation model as in idiopathic lupus. The DNA hypomethylation model may also provide an approach to predict additional aberrantly expressed genes in human lupus T cells, since CD11a, perforin, and CD70 were predicted by this model. Finally, these studies also suggest that environmental agents may act by mechanisms analogous to those seen in DIL, triggering changes in chromatin structure and affecting gene expression through signaling inhibition or direct DNA methyltransferase inhibition. Clearly, there is a fundamental role for a failure to maintain DNA methylation patterns and chromatin structure in this disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, R.L.P. and Burdon, R.H. (1985). DNA methylation in the cell. In A. Rich (ed.), Molecular Biology of DNA Methylation. Springer-Verlag, New York. pp. 9–18.
Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U., and Zoghbi, H.Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23, 185–188.
Antequera, F. and Bird, A. (1993). Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. U S A, 90, 11995–11999.
Attwood, J.T., Yung, R.L., and Richardson, B.C. (2002). DNA methylation and the regulation of gene transcription. Cell. Mol. Life Sci., 59, 241–257.
Baylin, S.B. and Herman, J.G. (2000). DNA hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends Genet., 16, 168–174.
Bestor, T.H. (1998). The host defence function of genomic methylation patterns. Novartis Foundation Symposium, 214, 187–195; discussion 195–199, 228–232.
Chuang, L.S., Ian, H.I., Koh, T.W., Ng, H.H., Xu, G., and Li, B.F. (1997). Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science, 277, 1996–2000.
Clark, S.J., Harrison, J., and Molloy, P.L. (1997). Sp1 binding is inhibited by (m)Cp(m)CpG methylation. Gene, 195, 67–171.
Comb, M. and Goodman, H.M. (1990). CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res., 18, 3975–3982.
Cornacchia, E., Golbus, J., Maybaum, J., Strahler, J., Hanash, S., and Richardson, B. (1988). Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J. Immunol., 140, 2197–2200.
Deng, C., Kaplan, M.J., Yang, J., Ray, D., Zhang, Z., McCune, W.J., Hanash, S.M., and Richardson, B.C. (2001). Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum., 44, 397–407.
Deng, C., Lu, Q., Zhang, Z., Rao, T., Attwood, J., Yung, R., and Richardson, B. (2003). Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum., 48, 746–756.
Deng, C., Yang, J., Scott, J., Hanash, S., and Richardson, B.C. (1998). Role of the Ras-MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation. Biol. Chem., 379, 1113–1120.
Ehrlich, M. and Wang, R.Y. (1981). 5-Methylcytosine in eukaryotic DNA. Science, 212, 1350–1357.
Gladman, D. (2004). Epidemiology of systemic lupus erythematosus. In R.G. Lahita (ed.), Systemic Lupus Erythematosus. Elsevier Academic, New York. pp. 697–715.
Glover, A.B. and Leyland-Jones, B. (1987). Biochemistry of azacitidine: A review. Cancer Treatm. Rep., 71, 959–964.
Goldstein, R. and Arnett, F.C. (1987). The genetics of rheumatic disease in man. Rheum. Dis. Clin. N Am., 13, 487–510.
Hansen, R.S., Wijmenga, C., Luo, P., Stanek, A.M., Canfield, T.K., Weemaes, C.M., and Gartler, S.M. (1999). The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl. Acad. Sci. U S A, 96, 14412–14417.
Hess, E.V. (1995). Environmental lupus syndromes. Br. J. Rheum., 34, 597–599.
Holliday, R. and Pugh, J.E. (1975). DNA modification mechanisms and gene activity during development. Science, 187, 226–232.
Kammer, G.M., Perl, A., Richardson, B.C., and Tsokos, G.C. (2002). Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum., 46, 1139–1154.
Kaplan, M.J., Beretta, L., Yung, R.L., and Richardson, B.C. (2000). LFA-1 overexpression and T cell autoreactivity: Mechanisms. Immunol. Invest., 29, 427–442.
Kaplan, M.J., Lu, Q., Wu, A., Attwood, J., and Richardson, B. (2004). Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J. Immunol., 172, 3652–3661.
Kobata, T., Jacquot, S., Kozlowski, S., Agematsu, K., Schlossman, S.F., and Morimoto, C. (1995). CD27-CD70 interactions regulate B-cell activation by T cells. Proc. Natl. Acad. Sci. U S A, 92, 11249–11253.
Kyttaris, V. and Tsokos, G. (2003). Uncovering the genetics of systemic lupus erythematosus: Implications for therapy. Am. J. Pharmacogenomics, 3, 193–202.
Lens, S.M., Tesselaar, K., van Oers, M.H., and van Lier, R.A. (1998). Control of lymphocyte function through CD27-CD70 interactions. Semin. Immunol., 10, 491–499.
Li, E., Bestor, T.H., and Jaenisch, R. (1992). Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell, 69, 915–926.
Liossis, S. and Tsokos, G. (1999). B cells in systemic lupus erythematosus. In G. Kammer and G. Tsokos (eds), Lupus. Molecular and Cellular Pathogenesis. Humana Press Inc, Totowa, New Jersey. pp. 167–180.
Lu, Q., Kaplan, M., Ray, D., Ray, D., Zacharek, S., Gutsch, D., and Richardson, B. (2002). Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum., 46, 1282–1291.
Lu, Q., Wu, A., Ray, D., Deng, C., Attwood, J., Hanash, S., Pipkin, M., Lichtenheld, M., and Richardson, B. (2003). DNA methylation and chromatin structure regulate T cell perforin gene expression. J. Immunol., 170, 5124–5132.
Mevorach, D., Zhou, J.L., Song, X., and Elkon, K.B. (1998). Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med., 188, 387–392.
Mongey, A.-B. and Hess, E.V. (2002). The role of environment in systemic lupus erythematosus and associated disorders. In D.J. Wallace and B.H. Hahn (eds), Dubois’s Lupus Erythematosus. Lippincott Williams and Wilkins, Philadelphia. pp. 33–64.
Oelke, K., Lu, Q., Richardson, D., Wu, A., Deng, C., Hanash, S., and Richardson, B. (2004). Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum., 50, 1850–1860.
Okano, M., Bell, D.W., Haber, D.A., and Li, E. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99, 247–257.
Okano, M., Xie, S., and Li, E. (1998a). Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res., 26, 2536–2540.
Okano, M., Xie, S., and Li, E. (1998b). Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet., 19, 219–220.
Quddus, J., Johnson, K.J., Gavalchin, J., Amento, E.P., Chrisp, C.E., Yung, R.L., and Richardson, B.C. (1993). Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J. Clin. Invest., 92, 38–53.
Richardson, B. (1986). Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells. Hum. Immunol., 17, 456–470.
Richardson, B., Kahn, L., Lovett, E.J., and Hudson, J. (1986). Effect of an inhibitor of DNA methylation on T cells. I. 5-Azacytidine induces T4 expression on T8+ T cells. J. Immunol., 137, 35–39.
Richardson, B., Powers, D., Hooper, F., Yung, R.L., and O’Rourke, K. (1994). Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum., 37, 1363–1372.
Richardson, B., Scheinbart, L., Strahler, J., Gross, L., Hanash, S., and Johnson, M. (1990). Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum., 33, 1665–1673.
Richardson, B.C., Buckmaster, T., Keren, D.F., and Johnson, K.J. (1993). Evidence that macrophages are programmed to die after activating autologous, cloned, antigen-specific, CD4+ T cells. E. J. Immunol., 23, 1450–1455.
Richardson, B.C., Liebling, M.R., and Hudson, J.L. (1990). CD4+ cells treated with DNA methylation inhibitors induce autologous B cell differentiation. Clin. Immunol. Immunopathol., 55, 368–381.
Richardson, B.C., Strahler, J.R., Pivirotto, T.S., Quddus, J., Bayliss, G.E., Gross, L.A., O’Rourke, K.S., Powers, D., Hanash, S.M., and Johnson, M.A. (1992). Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum., 35, 647–662.
Riggs, A.D. (1985). X-inactivation, DNA methylation, and differentiation revered. In A. Razin, H. Cedar, and A.D. Riggs (eds), DNA Methylation: Biochemistry and Biological Significance. Springer-Verlag, New York. pp. 269–278.
Scheinbart, L.S., Johnson, M.A., Gross, L.A., Edelstein, S.R., and Richardson, B.C. (1991). Procainamide inhibits DNA methyltransferase in a human T cell line. J. Rheumatol., 18, 530–534.
Stoger, R., Kubicka, P., Liu, C.G., Kafri, T., Razin, A., Cedar, H., and Barlow, D.P. (1993). Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell, 73, 61–71.
Tsao, B.P. and Grossman, J.M. (2001). Genetics and systemic lupus erythematosus. Curr. Rheumatol. Rep., 3, 183–190.
Walport, M.J. (2000). Lupus, DNase and defective disposal of cellular debris. Nat. Genet., 25, 135–136.
Yoder, J.A., Soman, N.S., Verdine, G.L., and Bestor, T.H. (1997). DNA (cytosine-5)-methyltrans-ferases in mouse cells and tissues. Studies with a mechanism-based probe. J. Mol. Biol., 270, 385–395.
Yu, F., Thiesen, J., and Stratling, W.H. (2000). Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2. Nucleic Acids Res., 28, 2201–2206.
Yung, R., Chang, S., Hemati, N., Johnson, K., and Richardson, B. (1997). Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo. Arthritis Rheum., 40, 1436–1443.
Yung, R., Kaplan, M., Ray, D., Schneider, K., Mo, R.R., Johnson, K., and Richardson, B. (2001). Autoreactive murine Th1 and Th2 cells kill syngeneic macrophages and induce autoantibodies. Lupus, 10, 539–546.
Yung, R., Powers, D., Johnson, K., Amento, E., Carr, D., Laing, T., Yang, J., Chang, S., Hemati, N., and Richardson, B. (1996). Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. J. Clin. Invest., 97, 2866–2871.
Yung, R.L., Quddus, J., Chrisp, C.E., Johnson, K.J., and Richardson, B.C. (1995). Mechanism of druginduced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J. Immunol., 154, 3025–3035.
Yung, R.L. and Richardson, B.C. (1994). Drug-induced lupus. Rheum. Dis. Clin. N. Am., 20, 61–86.
Yung, R.L. and Richardson, B.C. (2003). Drug-induced lupus. In M. Hochberg, A. Silman, J. Smolen, M. Weinblatt, and M. Weisman (eds) Rheumatology. Harcourt Health Sciences, London.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Ray, D., Richardson, B. (2005). Failure to Maintain T Cell DNA Methylation and Chromatin Structure Contributes to Human Lupus. In: Zouali, M. (eds) Molecular Autoimmunity. Springer, Boston, MA. https://doi.org/10.1007/0-387-24534-0_6
Download citation
DOI: https://doi.org/10.1007/0-387-24534-0_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-24533-1
Online ISBN: 978-0-387-24534-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)